Ubiquitin-specific peptidase 30-mediated deubiquitination of forkhead box O3 promotes the progression of subarachnoid hemorrhage by regulating cGAS/STING pathway.

泛素特异性肽酶 30 介导的叉头框 O3 去泛素化通过调节 cGAS/STING 通路促进蛛网膜下腔出血的进展

阅读:22
作者:Zhang Guiqiang, Xu Wenfeng
BACKGROUND: Subarachnoid hemorrhage (SAH) is a cerebrovascular disease with a very high disability and mortality rate, which brings a huge economic burden to society. It is reported that inhibition of forkhead box O3 (FOXO3) can alleviate brain edema and neuroinflammation after SAH. However, the role and mechanism of FOXO3 in regulating SAH progression need to be further studied. METHODS: Mouse microglia were treated with oxyhemoglobin (OxyHb) to build SAH cell model in vitro. Western blot was used to measure the protein levels of FOXO3, ubiquitin-specific peptidase 30 (USP30), embryonic lethal-abnormal vision like protein 1 (ELAVL1), and pyroptosis-related proteins. Cell proliferation was tested by cell counting kit 8 assay and 5-ethynyl-2' -deoxyuridine assay. Inflammatory factors were detected by ELISA, and cell polarization was evaluated using flow cytometry. Cell pyroptosis was assessed by detecting. Co-immunoprecipitation assay, immunofluorescence colocalization assay, and RNA immunoprecipitation assay were used to evaluate the interaction between FOXO3 and USP30 or ELAVL1. RESULTS: Downregulation of FOXO3 inhibited inflammation, M1 polarization, and pyroptosis in OxyHb-induced microglia. USP30 promoted FOXO3 expression through deubiquitination. USP30 knockdown suppressed inflammation, M1 polarization, and pyroptosis in OxyHb-induced microglia, and these effects were abolished by FOXO3 overexpression. Also, ELAVL1 interacted with FOXO3 to facilitate its mRNA stability. Meanwhile, USP30 increased FOXO3 expression to activate the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway. CONCLUSION: USP30-mediated deubiquitination of FOXO3 contributed to OxyHb-induced microglia inflammation, M1 polarization, and pyroptosis, providing a novel target for the treatment of SAH.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。